161 related articles for article (PubMed ID: 16879966)
1. Inhibition of HIV-1 integrase activity by synthetic peptides derived from the HIV-1 HXB2 Pol region of the viral genome.
Zawahir Z; Neamati N
Bioorg Med Chem Lett; 2006 Oct; 16(19):5199-202. PubMed ID: 16879966
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory profile of a LEDGF/p75 peptide against HIV-1 integrase: insight into integrase-DNA complex formation and catalysis.
Al-Mawsawi LQ; Christ F; Dayam R; Debyser Z; Neamati N
FEBS Lett; 2008 Apr; 582(10):1425-30. PubMed ID: 18331842
[TBL] [Abstract][Full Text] [Related]
3. Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.
Li HY; Zawahir Z; Song LD; Long YQ; Neamati N
J Med Chem; 2006 Jul; 49(15):4477-86. PubMed ID: 16854053
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).
Gleenberg IO; Herschhorn A; Hizi A
J Mol Biol; 2007 Jun; 369(5):1230-43. PubMed ID: 17490682
[TBL] [Abstract][Full Text] [Related]
5. A potent and orally active HIV-1 integrase inhibitor.
Egbertson MS; Moritz HM; Melamed JY; Han W; Perlow DS; Kuo MS; Embrey M; Vacca JP; Zrada MM; Cortes AR; Wallace A; Leonard Y; Hazuda DJ; Miller MD; Felock PJ; Stillmock KA; Witmer MV; Schleif W; Gabryelski LJ; Moyer G; Ellis JD; Jin L; Xu W; Braun MP; Kassahun K; Tsou NN; Young SD
Bioorg Med Chem Lett; 2007 Mar; 17(5):1392-8. PubMed ID: 17194584
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of novel nitrogen-containing polyhydroxylated aromatics as HIV-1 integrase inhibitors from caffeic acid phenethyl ester.
Wang P; Liu C; Sanches T; Zhong Y; Liu B; Xiong J; Neamati N; Zhao G
Bioorg Med Chem Lett; 2009 Aug; 19(16):4574-8. PubMed ID: 19625188
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.
Oz Gleenberg I; Herschhorn A; Goldgur Y; Hizi A
Arch Biochem Biophys; 2007 Feb; 458(2):202-12. PubMed ID: 17257575
[TBL] [Abstract][Full Text] [Related]
8. Investigations on the 4-quinolone-3-carboxylic acid motif. 1. Synthesis and structure-activity relationship of a class of human immunodeficiency virus type 1 integrase inhibitors.
Pasquini S; Mugnaini C; Tintori C; Botta M; Trejos A; Arvela RK; Larhed M; Witvrouw M; Michiels M; Christ F; Debyser Z; Corelli F
J Med Chem; 2008 Aug; 51(16):5125-9. PubMed ID: 18665580
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of substituted 4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-2-carboxamides, novel HIV-1 integrase inhibitors.
Langford HM; Williams PD; Homnick CF; Vacca JP; Felock PJ; Stillmock KA; Witmer MV; Hazuda DJ; Gabryelski LJ; Schleif WA
Bioorg Med Chem Lett; 2008 Jan; 18(2):721-5. PubMed ID: 18078751
[TBL] [Abstract][Full Text] [Related]
10. Symmetrical 1-pyrrolidineacetamide showing anti-HIV activity through a new binding site on HIV-1 integrase.
Du L; Zhao YX; Yang LM; Zheng YT; Tang Y; Shen X; Jiang HL
Acta Pharmacol Sin; 2008 Oct; 29(10):1261-7. PubMed ID: 18817633
[TBL] [Abstract][Full Text] [Related]
11. Single amino acid substitution in HIV-1 integrase catalytic core causes a dramatic shift in inhibitor selectivity.
Al-Mawsawi LQ; Sechi M; Neamati N
FEBS Lett; 2007 Mar; 581(6):1151-6. PubMed ID: 17328897
[TBL] [Abstract][Full Text] [Related]
12. Dynamic receptor-based pharmacophore model development and its application in designing novel HIV-1 integrase inhibitors.
Deng J; Lee KW; Sanchez T; Cui M; Neamati N; Briggs JM
J Med Chem; 2005 Mar; 48(5):1496-505. PubMed ID: 15743192
[TBL] [Abstract][Full Text] [Related]
13. 4-Hydroxy-5-pyrrolinone-3-carboxamide HIV-1 integrase inhibitors.
Pace P; Spieser SA; Summa V
Bioorg Med Chem Lett; 2008 Jul; 18(14):3865-9. PubMed ID: 18595690
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of novel dihydroquinoline-3-carboxylic acids as HIV-1 integrase inhibitors.
Sechi M; Rizzi G; Bacchi A; Carcelli M; Rogolino D; Pala N; Sanchez TW; Taheri L; Dayam R; Neamati N
Bioorg Med Chem; 2009 Apr; 17(7):2925-35. PubMed ID: 19026554
[TBL] [Abstract][Full Text] [Related]
15. Beta-diketo acid pharmacophore hypothesis. 1. Discovery of a novel class of HIV-1 integrase inhibitors.
Dayam R; Sanchez T; Clement O; Shoemaker R; Sei S; Neamati N
J Med Chem; 2005 Jan; 48(1):111-20. PubMed ID: 15634005
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and HIV-1 integrase inhibitory activity of dimeric and tetrameric analogs of indolicidin.
Krajewski K; Marchand C; Long YQ; Pommier Y; Roller PP
Bioorg Med Chem Lett; 2004 Nov; 14(22):5595-8. PubMed ID: 15482931
[TBL] [Abstract][Full Text] [Related]
17. Natural polymorphism of the HIV-1 integrase gene and mutations associated with integrase inhibitor resistance.
Lataillade M; Chiarella J; Kozal MJ
Antivir Ther; 2007; 12(4):563-70. PubMed ID: 17668566
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of trans-caffeate analogues and their bioactivities against HIV-1 integrase and cancer cell lines.
Xia CN; Li HB; Liu F; Hu WX
Bioorg Med Chem Lett; 2008 Dec; 18(24):6553-7. PubMed ID: 18952420
[TBL] [Abstract][Full Text] [Related]
19. Interfacial peptide inhibitors of HIV-1 integrase activity and dimerization.
Zhao L; O'Reilly MK; Shultz MD; Chmielewski J
Bioorg Med Chem Lett; 2003 Mar; 13(6):1175-7. PubMed ID: 12643937
[TBL] [Abstract][Full Text] [Related]
20. A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.
de Soultrait VR; Caumont A; Parissi V; Morellet N; Ventura M; Lenoir C; Litvak S; Fournier M; Roques B
J Mol Biol; 2002 Apr; 318(1):45-58. PubMed ID: 12054767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
